X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    New Delivery Path Brings To Light Efficacy of Immunotherapy

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    New Delivery Path Brings To Light Efficacy of Immunotherapy

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Americas

UPMC Invests in Private Rome Hospital, Plans Expansion of Specialized Services

Yuvraj_pawp by Yuvraj_pawp
21st September 2017
in Americas, News

In a move that will expand advanced cancer services and other specialized treatments to patients in central and southern Italy, UPMC announced today that it is making a strategic investment in Salvator Mundi International Hospital, a well-respected private facility near Rome’s city center. UPMC now owns a 50 percent stake in Salvator Mundi, with the rest held by the current hospital operator, Rome International Hospital Management Srl (RIHM).

“Given UPMC’s long-standing and successful operations in Italy, we are excited about partnering with RIHM to bring more high-quality services to patients who currently are underserved by both private and public health care providers,” said Charles Bogosta, president of UPMC International. “Our strategic investment in Salvator Mundi International ensures that this partnership will promote our mission of giving patients the best possible care close to home.”

Under the leadership of Michele Casciani, who is now chief executive officer of the hospital, Salvator Mundi has successfully revitalized the facility’s operations and finances in recent years, annually drawing about 2,400 admissions and performing about 3,000 surgeries and procedures. UPMC will lead the clinical operations of the 75-bed hospital, including designation of the medical director and chief operating officer.

“Backed by the deep clinical, operational and financial resources of UPMC, we look forward to offering our patients the most advanced medical and surgical oncology services, as well as highly specialized treatments in neurosurgery, interventional radiology and minimally invasive thoracic surgery,” said Casciani. “This partnership creates a model for private health care in Italy and the Mediterranean region, one based on clinical excellence and state-of-the-art technologies and processes.”

Salvator Mundi International is expected to benefit from efficiencies with UPMC’s other Italian operations, including radiotherapy center UPMC San Pietro FBF in Rome, transplant hospital ISMETT in Palermo, the UPMC Institute for Health at the Terme di Chianciano Spa in Chianciano Terme, an outpatient diagnostic and wellness center, and the planned Biomedical Research and Biotechnology Center in Carini. With UPMC’s assistance, Salvator Mundi also aims to achieve Joint Commission International accreditation, enhancing its reputation for high quality, just as UPMC-owned or affiliated facilities have already done in Italy, Ireland and China.

Founded in 1951, Salvator Mundi International was managed by the Sisters of the Divine Savior, an Italian Roman Catholic congregation, until 2012. Operated since that time by RIHM, the hospital has modernized facilities and expanded its base of more than 350 independent physicians, offering a wide range of services in general medicine, surgery, urology, orthopaedics, gynecology, gastroenterology, radiology and other service lines.

Tags: America
Previous Post

New Nymalize Oral Solution 10 mL Unit Dose for the Treatment of Subarachnoid Hemorrhage launched by Arbor Pharma

Next Post

Juno Therapeutics Opens New Headquarters and Research Center

Related Posts

Drug Development

New Delivery Path Brings To Light Efficacy of Immunotherapy

1st April 2023
Quotient Sciences completes integration of drug substance into Translational Pharmaceutics Platform
Facilities & Operation

£277m Funding Set To Benefit UK Life Sciences Manufacturing

31st March 2023
Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Next Post

Juno Therapeutics Opens New Headquarters and Research Center

Latest News

Drug Development

New Delivery Path Brings To Light Efficacy of Immunotherapy

1st April 2023
Cathay Cargo signs global airline partnership with Tower Cold Chain
Packaging & Logistic

Cathay Cargo signs global airline partnership with Tower Cold Chain

31st March 2023
Quotient Sciences completes integration of drug substance into Translational Pharmaceutics Platform
Facilities & Operation

£277m Funding Set To Benefit UK Life Sciences Manufacturing

31st March 2023
Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In